Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non-Infectious Uveitis”

125 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 125 results

Testing effectiveness (Phase 2)Ended earlyNCT00646425
What this trial is testing

The Safety and Efficacy of Basiliximab as Maintenance Therapy in Subjects With Stable, Noninfectious Uveitis

Who this might be right for
Non-infectious Uveitis
Cerimon Pharmaceuticals 5
Not applicableStudy completedNCT02916017
What this trial is testing

HUMIRA® Long-term Treatment in Patients With Non-infectious Intermediate-, Posterior-, or Pan-uveitis

Who this might be right for
Uveitis
AbbVie 259
Testing effectiveness (Phase 2)Study completedNCT01526889
What this trial is testing

Safety,Tolerability and Efficacy of Intravitreal LFG316 in Patients With Active Non-infectious Intermediate-, posterior-or Panuveitis ,

Who this might be right for
Non-infectious Intermediate UveitisNon-infectious Posterior UveitisNon-infectious Panuveitis
Novartis Pharmaceuticals 25
Post-approval studies (Phase 4)WithdrawnNCT05101928
What this trial is testing

Ozurdex Monotherapy Trial

Who this might be right for
Uveitis, PosteriorUveitis, IntermediatePanuveitis
Ottawa Hospital Research Institute
Large-scale testing (Phase 3)WithdrawnNCT01327664
What this trial is testing

Study to Evaluate the Long Term Use of Treatment With AIN457 for Uveitis

Who this might be right for
Uveitis
Novartis Pharmaceuticals
Testing effectiveness (Phase 2)Looking for participantsNCT07552012
What this trial is testing

A Phase II Clinical Trial to Evaluate the Efficacy and Safety of FXS5626 in Patients With NIU

Who this might be right for
Active Non-anterior, Non-infectious Uveitis
Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd. 40
Testing effectiveness (Phase 2)Study completedNCT00615693
What this trial is testing

Safety, Tolerability, and Efficacy of AEB071 in the Treatment of Uveitis

Who this might be right for
UveitisPosterior UveitisPanuveitis
Novartis 13
Post-approval studies (Phase 4)Active Not RecruitingNCT05322070
What this trial is testing

Fluocinolone Acetonide Intravitreal Implant 0.18 mg in the Treatment of Chronic Non-Infectious Posterior Segment Uveitis

Who this might be right for
Uveitis, Posterior
Alimera Sciences 125
Testing effectiveness (Phase 2)Study completedNCT00070759
What this trial is testing

Daclizumab to Treat Non-Infectious Sight-Threatening Uveitis

Who this might be right for
Uveitis
National Eye Institute (NEI) 6
Testing effectiveness (Phase 2)Study completedNCT01564108
What this trial is testing

The LIMO Study, Lucentis for Treatment of Uveitic Patients With Refractory Cystoid Macular Oedema

Who this might be right for
Uveitis Related Cystoid Macular EdemaSteroid-induced Glaucoma - Borderline
Moorfields Eye Hospital NHS Foundation Trust 10
Large-scale testing (Phase 3)Not Yet RecruitingNCT06258915
What this trial is testing

Treatment FOr Corticosteroid Dependent UveitiS

Who this might be right for
Non Infectious Uveitis
Assistance Publique - Hôpitaux de Paris 120
Large-scale testing (Phase 3)Study completedNCT03131154
What this trial is testing

SOLACE Trial - A Phase 3 Trial in Subjects With Non-infectious Anterior-uveitis.

Who this might be right for
Non-infectious Anterior Uveitis
Aldeyra Therapeutics, Inc. 123
Early research (Phase 1)Not Yet RecruitingNCT07427628
What this trial is testing

A Proof-of-concept Trial to EvaluAte the efficaCy and Safety Of Cell Therapy TRX103 in Patients With Active, Non-infectious Uveitis

Who this might be right for
Non Infectious Uveitis
Quan Dong Nguyen 18
Post-approval studies (Phase 4)Looking for participantsNCT06539481
What this trial is testing

Open Label Trial Studying the Safety and Effectiveness of ILUVIEN® (190μg) in Children and Adolescents, Who Have Recurrent Non-infectious Uveitis Affecting the Posterior Segment of the Eye.

Who this might be right for
Non-infectious Uveitis Affecting the Posterior Segment of the Eye
Alimera Sciences 25
Testing effectiveness (Phase 2)Study completedNCT04706741
What this trial is testing

A Trial of the Efficacy and Safety of Izokibep in the Treatment of Non-anterior Uveitis

Who this might be right for
Uveitis
ACELYRIN Inc. 7
Large-scale testing (Phase 3)Study completedNCT03097315
What this trial is testing

Suprachoroidal Injection of CLS-TA in Patients With Non-infectious Uveitis

Who this might be right for
UveitisUveitis, PosteriorUveitis, Anterior+2 more
Clearside Biomedical, Inc. 38
Large-scale testing (Phase 3)Ended earlyNCT02258854
What this trial is testing

An Open-label, Rollover Study Providing Continued Dosing of Gevokizumab in Order to Assess Long-term Gevokizumab Safety Data

Who this might be right for
Uveitis
XOMA (US) LLC 69
Not applicableStudy completedNCT03155243
What this trial is testing

Impact of Humira® Therapy on Ocular Inflammation, Selected Health Care Resource Utilization and Patient Reported Outcomes in Patients With Active Non-infectious Intermediate, Posterior and Panuveitis in Routine Clinical Practice

Who this might be right for
Uveitis
AbbVie 155
Large-scale testing (Phase 3)Ended earlyNCT01684345
What this trial is testing

Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis

Who this might be right for
Uveitis
XOMA (US) LLC 200
Large-scale testing (Phase 3)Study completedNCT02748512
What this trial is testing

Utilization and Safety of the Mk II Inserter and the Safety of the FAI Insert in Non-Infectious Uveitis

Who this might be right for
Non-Infectious Uveitis
EyePoint Pharmaceuticals, Inc. 26
Load More Results